483
Long Grove Pharmaceuticals LLCLong Grove Pharmaceuticals LLC – FDA 483, Nov 6, 2024
Record Details
Long Grove Pharmaceuticals, LLC, an application holder and distributor for drug products, was cited for significant deficiencies during an FDA inspection. The firm lacks a functional quality control unit, written procedures for quality unit responsibilities, and failed to adequately investigate a complaint regarding potential bacterial contamination in a distributed drug product. These observations indicate serious non-compliance with regulatory requirements.
View Company Profile
ID · b3f64c36-e62e-4432-94e6-f1cf0304baf2
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.